End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.18 CNY | -1.22% | +2.44% | -10.31% |
May. 29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
May. 29 | Hybio Pharmaceutical Grants Commercial Rights of Weight Loss Drug to Sansheng Mandi Pharmaceutical | MT |
Business Summary
Number of employees: 895
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Preparation
48.1
%
| 575 | 81.7 % | 208 | 48.1 % | -63.91% |
Active Pharmaceutical Ingredient
28.1
%
| 90 | 12.7 % | 121 | 28.1 % | +35.36% |
Other
11.2
%
| 12 | 1.7 % | 48 | 11.2 % | +300.95% |
Solid
9.8
%
| 22 | 3.2 % | 42 | 9.8 % | +90.17% |
Consumer Goods and Others
1.6
%
| 1 | 0.1 % | 7 | 1.6 % | +766.80% |
Client Peptide
1.0
%
| 3 | 0.4 % | 4 | 1.0 % | +45.98% |
Equipment
0.1
%
| 1 | 0.2 % | 0 | 0.1 % | -78.70% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
74.0
%
| 625 | 88.7 % | 319 | 74.0 % | -48.94% |
Foreign
26.0
%
| 79 | 11.3 % | 112 | 26.0 % | +41.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Pin Xiang
CEO | Chief Executive Officer | 51 | 19-05-30 |
Hong Hong Tu
DFI | Director of Finance/CFO | 48 | 21-07-07 |
Yang Ming Tang
BRD | Director/Board Member | 46 | 21-01-28 |
Di Yang
BRD | Director/Board Member | - | 20-04-05 |
Ping Ping Li
IRC | Investor Relations Contact | - | 22-01-24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lian Zhong
BRD | Director/Board Member | 63 | 21-08-22 |
Shao Gui Zeng
CHM | Chairman | 56 | 09-10-26 |
Shao Qiang Zeng
BRD | Director/Board Member | 53 | 09-10-26 |
Shao Bin Zeng
BRD | Director/Board Member | 47 | 20-01-14 |
Wen Yan Hu
BRD | Director/Board Member | 54 | 21-11-29 |
Yu Pin Xiang
CEO | Chief Executive Officer | 51 | 19-05-30 |
Di Yang
BRD | Director/Board Member | - | 20-04-05 |
Qing Yang Li
CHM | Chairman | 48 | 20-03-03 |
Lu Yang
BRD | Director/Board Member | 42 | 21-08-21 |
Lin Liang
BRD | Director/Board Member | 47 | 21-11-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 883,241,336 | 576,765,562 ( 65.30 %) | 0 | 65.30 % |
Company contact information
Hybio Pharmaceutical Co.. Ltd.
Hanyu Innovation Industry Building No. 7 Guansheng 4th Road
518057, Shenzhen
+
http://www.hybio.com.cnSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-10.31% | 1.49B | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-0.05% | 6.79B | |
-9.58% | 6.8B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 300199 Stock
- Company Hybio Pharmaceutical Co., Ltd.